Takeda Pharmaceutical (TAK) Other financing activities (2018 - 2020)

Takeda Pharmaceutical's Other financing activities history runs 3 years deep, the most recent figure standing at -$20.1 million for Q1 2020.

• In Q1 2020, Other financing activities rose 81.43% year-over-year to -$20.1 million; the TTM figure through Mar 2020 stood at -$144.0 million (down 10.48% YoY), while the FY2025 annual figure was -$109.3 million, up 39.62% from the prior year.
• Other financing activities was -$20.1 million for Q1 2020 at Takeda Pharmaceutical, down from -$15.5 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of -$15.5 million in Q2 2019 to a low of -$108.4 million in Q1 2019.
• Historically, Other financing activities has averaged -$41.5 million across 3 years, with a median of -$21.0 million in 2020.
• The sharpest annual moves came in 2019 and 2020: Other financing activities climbed 29.53% in 2019, then soared 81.43% in 2020.
• A 3-year view of Other financing activities shows it stood at -$21.9 million in 2018, then gained by 29.53% to -$15.5 million in 2019, then sank by 30.28% to -$20.1 million in 2020.
• The last three Other financing activities figures came in at -$20.1 million (Q1 2020), -$15.5 million (Q2 2019), and -$108.4 million (Q1 2019), per Business Quant data.